AMH Medicines

AMH Medicines is a trusted, independent source of concise and evidence-based medicines information, designed for everyday Australian healthcare practice. It provides clear, comparative information to support informed clinical decisions at the point of care.

July 2026 key updates - Online and Desktop App

  • new drugs, eg ublituximab for MS, vanzacaftor with tezacaftor and deutivacaftor for cystic fibrosis
  • new indications, including semaglutide for metabolic dysfunction-associated steatohepatitis, finerenone for heart failure, and obinutuzumab for lupus nephritis
  • reviewed and updated information on the management of osteoarthritis
  • terminology updates, eg antiepileptics changed to antiseizure drugs
  • new formulations added, eg intranasal adrenaline, intranasal influenza vaccine
  • removed recently discontinued drugs, eg fluvastatin, and formulations, eg oxycodone suppositories.

The update also includes many smaller changes across AMH Medicines. For a complete overview, see the Summary of key changes.

AMH Children's Dosing

AMH Children’s Dosing is a trusted source of medicines dosing information to support informed paediatric prescribing and clinical care. It provides evidence-based dosing guidance for safer, smarter decision-making in the care of infants, children and adolescents across Australian healthcare settings.

July 2026 key updates - Book release and Online content updates

  • vanzacaftor with tezacaftor and deutivacaftor combination for cystic fibrosis
  • doses added for adrenaline (epinephrine) nasal spray for anaphylaxis
  • updated dosing advice for levetiracetam, metronidazole and tetracosactide
  • a safety reminder for benzylpenicillin and benzathine benzylpenicillin

The update also includes many smaller changes across AMH Children's Dosing. For a complete overview, see the Summary of key changes.

Find out more

AMH Aged Care

AMH Aged Care is a condition-based source of information on the management of common clinical conditions in Australian aged care practice. It supports healthcare professionals in managing the complex care needs of older people, with clear and evidence-based guidance on medicines and other treatment options.

May 2026 key updates - Book release and Online content updates

  • updated topics including asthma, coronary heart disease, depression, dyslipidaemia, fall prevention, heart failure, nausea and vomiting, osteoporosis
  • terminology updates, eg aldosterone antagonists changed to mineralocorticoid receptor antagonists, hormone replacement therapy to menopausal hormone therapy.

The update also includes many smaller changes across AMH Aged Care. For a complete overview, see the Summary of key changes.

Find out more

Beware - buying electronic AMH products from other sources

Electronic versions of all AMH products are ONLY available for purchase from the AMH website. Any other website advertising the sale of AMH products may contain malicious software that may harm the integrity of your computer.

Likewise, any unauthorised email offer on these products could be spam. If you are unsure of its content, please delete the email and report the incident to us via sales@amh.net.au

To buy AMH print products, please go to the support page of the AMH website and select AMH Stockists found under the heading Where to buy AMH products.